Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran.
Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
J Transl Med. 2024 May 8;22(1):435. doi: 10.1186/s12967-024-05226-3.
Diabetes mellitus is a significant global public health challenge, with a rising prevalence and associated morbidity and mortality. Cell therapy has evolved over time and holds great potential in diabetes treatment. In the present review, we discussed the recent progresses in cell-based therapies for diabetes that provides an overview of islet and stem cell transplantation technologies used in clinical settings, highlighting their strengths and limitations. We also discussed immunomodulatory strategies employed in cell therapies. Therefore, this review highlights key progresses that pave the way to design transformative treatments to improve the life quality among diabetic patients.
糖尿病是一个重大的全球公共卫生挑战,其患病率不断上升,导致发病率和死亡率上升。随着时间的推移,细胞疗法也在不断发展,在糖尿病治疗方面具有巨大的潜力。在本综述中,我们讨论了用于糖尿病的基于细胞的治疗方法的最新进展,概述了临床应用中使用的胰岛和干细胞移植技术,强调了它们的优势和局限性。我们还讨论了细胞治疗中使用的免疫调节策略。因此,本综述强调了为设计变革性治疗方法以改善糖尿病患者的生活质量铺平道路的关键进展。